Hero MotoCorp's board has approved up to ₹1,000 crore in additional investment into EV maker Ather Energy. Here's what the deepening partnership signals about India's two-wheeler EV race.
GIFT Nifty futures are pointing to another flat, cautious open. Here's why persistent FII selling, DII buying, and an earnings-season overhang are keeping Indian markets locked in a narrow range.
Negotiators call it the 'last 1 percent.' But with a July 22-24 tariff deadline bearing down, forced-labour clauses and Asian tariff parity are still unresolved. Here's what's actually on the table.
x is scaling its AI Force platform to deploy agentic AI capabilities for enterprise clients, including a major insurance partnership. Here's what agentic AI actually means for India's IT services industry.
RBI has introduced comprehensive new rules governing how banks acquire, value, and dispose of properties taken over from defaulting borrowers. Here's what changes — and why it matters beyond the banking sector.
The Sensex fell over 0.5% on July 14 amid weak global sentiment, even as healthcare stocks bucked the trend. A closer look at what drove the selloff — and why its effects are still rippling through this week's trading.
Crisil says India's debt capital market needs to expand dramatically to support a $30 trillion economy by 2047. Here's why bank-dominated financing has been the norm — and what deepening the bond market would actually take.
RIL's Q4 FY26 net profit fell 12.55% year-on-year to ₹16,971 crore. Before today's Q1 FY27 numbers land, here's a deep dive into what went wrong last quarter — and whether it was a one-off or a warning sign.
Tata Capital raised $400 million through a 3.5-year dollar bond at 107 basis points over Treasuries — the tightest pricing for any Indian investment-grade dollar bond in 2026. Here's how they did it.
Dr. Reshma Kewalramani became the first female CEO of a major US biotech company when she took the helm of Vertex Pharmaceuticals in 2020. A Mumbai-born nephrologist turned Fortune 500 leader, she was named to TIME's 2026 Women of the Year list for reshaping what's possible in life sciences leadership.